$ORRF
ORRSTOWN FINANCIAL SERVICES INC Stock $orrf

$orrf Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000082615422000128 Filed on May 05, 2022

Income Statement

Concept	2022 Q1	2021 Q1	2020 Q4
Revenue	$23.79M	$23.93M
YoY Change	-0.58%	-0.16%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.210M	$1.350M	$1.590M
YoY Change	-10.37%	-2.88%	0.63%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$1.217M	$2.074M
YoY Change	-41.32%	-63.65%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$10.38M	$12.62M	$12.53M
YoY Change	-17.7%	106.58%	138.21%
Income Tax	$2.015M	$2.409M	$2.470M
% Of Pretax Income	19.41%	19.09%	19.71%
Net Earnings	$8.368M	$10.21M	$10.06M
YoY Change	-18.02%	101.4%	137.83%
Net Earnings / Revenue	35.17%	42.66%
Basic Earnings Per Share	$0.77	$0.93
Diluted Earnings Per Share	$0.76	$0.92	$909.6K
COMMON SHARES
Basic Shares Outstanding	10.86M shares	10.98M shares	11.20M shares
Diluted Shares Outstanding	11.01M shares	11.07M shares

Balance Sheet

Concept	2022 Q1	2021 Q1	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$214.2M	$326.2M	$125.3M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$33.70M	$34.72M	$35.15M
YoY Change	-2.92%	-6.41%	-6.33%
Goodwill	$18.72M	$18.72M	$18.72M
YoY Change	0.0%	-7.04%	-6.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$12.90M
YoY Change			7.5%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.901B	$2.964B	$2.751B
YoY Change	-2.13%	24.12%	15.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$30.41M	$39.10M	$28.90M
YoY Change	-22.21%	49.24%	-16.71%
Accrued Expenses	$10.94M	$10.20M	$9.100M
YoY Change	7.23%	7.37%
Deferred Revenue
YoY Change
Short-Term Debt	$24.62M	$22.80M	$19.47M
YoY Change	8.0%	109.17%	135.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$41.35M	$49.30M	$38.00M
YoY Change	-16.12%	38.1%	9.51%
LONG-TERM LIABILITIES
Long-Term Debt	$31.98M	$31.90M	$31.90M
YoY Change	0.24%	0.0%	0.31%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$31.98M	$31.90M	$31.90M
YoY Change	0.24%	0.0%	0.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$41.35M	$49.30M	$38.00M
Total Long-Term Liabilities	$31.98M	$31.90M	$31.90M
Total Liabilities	$2.646B	$2.709B	$2.504B
YoY Change	-2.34%	24.44%	15.94%
SHAREHOLDERS EQUITY
Retained Earnings	$84.94M	$62.30M	$54.10M
YoY Change	36.34%	62.21%	53.49%
Common Stock	$585.0K	$586.0K	$586.0K
YoY Change	-0.17%	0.0%	0.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$4.083M	$266.0K	$848.0K
YoY Change	1434.96%	-77.26%	81.97%
Treasury Stock Shares	168.6K shares	14.76K shares	55.73K shares
Shareholders Equity	$254.8M	$254.4M	$246.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.901B	$2.964B	$2.751B
YoY Change	-2.13%	24.12%	15.41%

Cashflow Statement

Concept	2022 Q1	2021 Q1	2020 Q4
OPERATING ACTIVITIES
Net Income	$8.368M	$10.21M	$10.06M
YoY Change	-18.02%	101.4%	137.83%
Depreciation, Depletion And Amortization	$1.210M	$1.350M	$1.590M
YoY Change	-10.37%	-2.88%	0.63%
Cash From Operating Activities	$6.642M	$16.63M	$13.83M
YoY Change	-60.07%	275.38%	145.65%
INVESTING ACTIVITIES
Capital Expenditures	$235.0K	$156.0K	-$390.0K
YoY Change	50.64%	87.95%	-221.88%
Acquisitions
YoY Change
Other Investing Activities	-$76.72M	-$6.470M	-$395.3M
YoY Change	1085.78%	-58.87%	474.03%
Cash From Investing Activities	-$76.96M	-$6.625M	-$395.7M
YoY Change	1061.58%	-58.11%	477.21%
FINANCING ACTIVITIES
Cash Dividend Paid	$2.125M	$2.004M
YoY Change	6.04%	5.14%
Common Stock Issuance & Retirement, Net	$4.166M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$75.84M	$191.0M	419.8M
YoY Change	-60.29%	1420.9%	513.37%
NET CHANGE
Cash From Operating Activities	$6.642M	$16.63M	13.83M
Cash From Investing Activities	-$76.96M	-$6.625M	-395.7M
Cash From Financing Activities	$75.84M	$191.0M	419.8M
Net Change In Cash	$5.528M	$201.0M	37.94M
YoY Change	-97.25%	17019.85%	587.32%
FREE CASH FLOW
Cash From Operating Activities	$6.642M	$16.63M	$13.83M
Capital Expenditures	$235.0K	$156.0K	-$390.0K
Free Cash Flow	$6.407M	$16.48M	$14.22M
YoY Change	-61.12%	278.96%	167.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000826154
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2022Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2015Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	416000	shares
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-34292
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	ORRSTOWN FINANCIAL SERVICES, INC.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	PA
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	23-2530374
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	77 East King Street
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	P. O. Box 250
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Shippensburg
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	17257
CY2022Q1	dei	City Area Code CityAreaCode	(717)
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	532-6114
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, no par value
CY2022Q1	dei	Trading Symbol TradingSymbol	ORRF
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11054814	shares
CY2022Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	26446000	USD
CY2021Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	21217000	USD
CY2022Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	187792000	USD
CY2021Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	187493000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	214238000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Federal Funds Sold CashCashEquivalentsAndFederalFundsSold	208710000	USD
CY2022Q1	us-gaap	Restricted Investments RestrictedInvestments	6791000	USD
CY2021Q4	us-gaap	Restricted Investments RestrictedInvestments	7252000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	548305000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	466806000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	529730000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	472438000	USD
CY2022Q1	orrf	Loans Receivable Held For Sale At Fair Value LoansReceivableHeldForSaleAtFairValue	7403000	USD
CY2021Q4	orrf	Loans Receivable Held For Sale At Fair Value LoansReceivableHeldForSaleAtFairValue	8868000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1978307000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1979986000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21508000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21180000	USD
CY2022Q1	us-gaap	Notes Receivable Net NotesReceivableNet	1956799000	USD
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	1958806000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33704000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34045000	USD
CY2022Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	70622000	USD
CY2021Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	70217000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	18724000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	18724000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3891000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4183000	USD
CY2022Q1	us-gaap	Interest Receivable InterestReceivable	8642000	USD
CY2021Q4	us-gaap	Interest Receivable InterestReceivable	8234000	USD
CY2022Q1	us-gaap	Other Assets OtherAssets	49993000	USD
CY2021Q4	us-gaap	Other Assets OtherAssets	43088000	USD
CY2022Q1	us-gaap	Assets Assets	2900537000	USD
CY2021Q4	us-gaap	Assets Assets	2834565000	USD
CY2022Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	557756000	USD
CY2021Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	553238000	USD
CY2022Q1	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1988236000	USD
CY2021Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	1911691000	USD
CY2022Q1	us-gaap	Deposits Deposits	2545992000	USD
CY2021Q4	us-gaap	Deposits Deposits	2464929000	USD
CY2022Q1	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	24624000	USD
CY2021Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	23301000	USD
CY2022Q1	orrf	Federal Home Loan Bank Advances And Other Borrowings FederalHomeLoanBankAdvancesAndOtherBorrowings	1788000	USD
CY2021Q4	orrf	Federal Home Loan Bank Advances And Other Borrowings FederalHomeLoanBankAdvancesAndOtherBorrowings	1896000	USD
CY2022Q1	us-gaap	Subordinated Debt SubordinatedDebt	31978000	USD
CY2021Q4	us-gaap	Subordinated Debt SubordinatedDebt	31963000	USD
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	41351000	USD
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	40820000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	2645733000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	2562909000	USD
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.25
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.25
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05205
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.05205
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11247545	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11078990	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11258167	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11183050	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	585000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	586000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	188033000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	189689000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	84943000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	78700000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14674000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4449000	USD
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	168555	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	75117	shares
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	4083000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1768000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	254804000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	271656000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2900537000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2834565000	USD
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	21369000	USD
CY2021Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	21511000	USD
CY2022Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1598000	USD
CY2021Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	1879000	USD
CY2022Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	722000	USD
CY2021Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	500000	USD
CY2022Q1	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	101000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Securities Other InterestAndDividendIncomeSecuritiesOther	39000	USD
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	23790000	USD
CY2021Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	23929000	USD
CY2022Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	685000	USD
CY2021Q1	us-gaap	Interest Expense Deposits InterestExpenseDeposits	1392000	USD
CY2022Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	7000	USD
CY2021Q1	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	9000	USD
CY2022Q1	orrf	Interest Expense Federal Home Loan Bank Advances And Other Overnight Borrowings InterestExpenseFederalHomeLoanBankAdvancesAndOtherOvernightBorrowings	22000	USD
CY2021Q1	orrf	Interest Expense Federal Home Loan Bank Advances And Other Overnight Borrowings InterestExpenseFederalHomeLoanBankAdvancesAndOtherOvernightBorrowings	171000	USD
CY2022Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	503000	USD
CY2021Q1	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	502000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	1217000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	2074000	USD
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	22573000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	21855000	USD
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	300000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1000000	USD
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	22273000	USD
CY2021Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	22855000	USD
CY2022Q1	orrf	Non Interest Income Service Charges On Deposits NonInterestIncomeServiceChargesOnDeposits	920000	USD
CY2021Q1	orrf	Non Interest Income Service Charges On Deposits NonInterestIncomeServiceChargesOnDeposits	737000	USD
CY2022Q1	orrf	Merchant And Bankcard Fees Interchange Income MerchantAndBankcardFeesInterchangeIncome	981000	USD
CY2021Q1	orrf	Merchant And Bankcard Fees Interchange Income MerchantAndBankcardFeesInterchangeIncome	955000	USD
CY2022Q1	orrf	Non Interest Income Fess And Commissions Other NonInterestIncomeFessAndCommissionsOther	153000	USD
CY2021Q1	orrf	Non Interest Income Fess And Commissions Other NonInterestIncomeFessAndCommissionsOther	148000	USD
CY2022Q1	orrf	Loan Swap Referral Fees LoanSwapReferralFees	953000	USD
CY2021Q1	orrf	Loan Swap Referral Fees LoanSwapReferralFees	53000	USD
CY2022Q1	us-gaap	Investment Banking Revenue InvestmentBankingRevenue	1941000	USD
CY2021Q1	us-gaap	Investment Banking Revenue InvestmentBankingRevenue	1912000	USD
CY2022Q1	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	928000	USD
CY2021Q1	us-gaap	Brokerage Commissions Revenue BrokerageCommissionsRevenue	811000	USD
CY2022Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	721000	USD
CY2021Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	2189000	USD
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	566000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	557000	USD
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-146000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	145000	USD
CY2022Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	457000	USD
CY2021Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	37000	USD
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	7474000	USD
CY2021Q1	us-gaap	Noninterest Income NoninterestIncome	7544000	USD
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11337000	USD
CY2021Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10197000	USD
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	1288000	USD
CY2021Q1	us-gaap	Occupancy Net OccupancyNet	1240000	USD
CY2022Q1	us-gaap	Equipment Expense EquipmentExpense	1279000	USD
CY2021Q1	us-gaap	Equipment Expense EquipmentExpense	1278000	USD
CY2022Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1053000	USD
CY2021Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1019000	USD
CY2022Q1	orrf	Automated Teller And Interchange Fees AutomatedTellerAndInterchangeFees	305000	USD
CY2021Q1	orrf	Automated Teller And Interchange Fees AutomatedTellerAndInterchangeFees	249000	USD
CY2022Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	355000	USD
CY2021Q1	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	425000	USD
CY2022Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	283000	USD
CY2021Q1	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	194000	USD
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	808000	USD
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	721000	USD
CY2022Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	231000	USD
CY2021Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	234000	USD
CY2022Q1	us-gaap	Taxes Other TaxesOther	564000	USD
CY2021Q1	us-gaap	Taxes Other TaxesOther	451000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	292000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	334000	USD
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1569000	USD
CY2021Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	1441000	USD
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	19364000	USD
CY2021Q1	us-gaap	Noninterest Expense NoninterestExpense	17783000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10383000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12616000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2015000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2409000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8368000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	10207000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.19
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.18
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8368000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	10207000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-24353000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-721000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-146000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	145000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-24207000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-866000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-5084000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax	-182000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-19123000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-684000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	739000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax	-87000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax	826000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax	-173000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	653000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19123000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10755000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10176000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	271656000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8368000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-19123000	USD
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.19
CY2022Q1	us-gaap	Dividends Cash DividendsCash	2125000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	10622	shares
CY2022Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	93438	shares
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	338000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-3972000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	254804000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	246249000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	10207000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-31000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.18
CY2021Q1	us-gaap	Dividends Cash DividendsCash	2004000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	8671	shares
CY2021Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	40970	shares
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	467000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	27000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	254448000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8368000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	10207000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-68000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	738000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1210000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1353000	USD
CY2022Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	300000	USD
CY2021Q1	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	-1000000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	338000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	467000	USD
CY2022Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	319000	USD
CY2021Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	1320000	USD
CY2022Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	32903000	USD
CY2021Q1	us-gaap	Increase Decrease In Mortgage Loans Held For Sale IncreaseDecreaseInMortgageLoansHeldForSale	55720000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	32749000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	56959000	USD
CY2022Q1	orrf	Gain Loss On Sale Of Portfolio Loans GainLossOnSaleOfPortfolioLoans	271000	USD
CY2021Q1	orrf	Gain Loss On Sale Of Portfolio Loans GainLossOnSaleOfPortfolioLoans	0	USD
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2022Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1638000	USD
CY2021Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	1600000	USD
CY2022Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-146000	USD
CY2021Q1	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	145000	USD
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	566000	USD
CY2021Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	557000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	408000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	143000	USD
CY2022Q1	orrf	Increase Decrease In Accrued Interest Payable And Other Liabilities IncreaseDecreaseInAccruedInterestPayableAndOtherLiabilities	531000	USD
CY2021Q1	orrf	Increase Decrease In Accrued Interest Payable And Other Liabilities IncreaseDecreaseInAccruedInterestPayableAndOtherLiabilities	12095000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	4251000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	3225000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6642000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	16633000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3075000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	75736000	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	9536000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	11406000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	94903000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	29233000	USD
CY2022Q1	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-461000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-256000	USD
CY2022Q1	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	1146000	USD
CY2021Q1	us-gaap	Proceeds From Limited Partnership Investments ProceedsFromLimitedPartnershipInvestments	0	USD
CY2022Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	-52000	USD
CY2021Q1	us-gaap	Payments For Proceeds From Loans And Leases PaymentsForProceedsFromLoansAndLeases	64634000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	3913000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Loans Receivable ProceedsFromSaleOfLoansReceivable	0	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	235000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	156000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76955000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6625000	USD
CY2022Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	81060000	USD
CY2021Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	190198000	USD
CY2022Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	1323000	USD
CY2021Q1	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	3328000	USD
CY2022Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	108000	USD
CY2021Q1	us-gaap	Repayments Of Federal Home Loan Bank Borrowings RepaymentsOfFederalHomeLoanBankBorrowings	103000	USD
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2125000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	2004000	USD
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4166000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2022Q1	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Liability ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureLiability	1600000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	232000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	514000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	89000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	74000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	75841000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	190979000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5528000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	200987000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208710000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125258000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	214238000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	326245000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	710000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	1629000	USD
CY2022Q1	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	1510000	USD
CY2021Q1	us-gaap	Transfer Of Loans Held For Sale To Portfolio Loans1 TransferOfLoansHeldForSaleToPortfolioLoans1	0	USD
CY2022Q1	orrf	Securities Purchased Not Settled SecuritiesPurchasedNotSettled	0	USD
CY2021Q1	orrf	Securities Purchased Not Settled SecuritiesPurchasedNotSettled	11699000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	548305000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	2035000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	20610000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	529730000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	466806000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	9487000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3855000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	472438000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	74	security
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	416558000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	19865000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	4	security
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	35411000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	745000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	78	security
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	451969000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	20610000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	37	security
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	190192000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	3693000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	3	security
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	34180000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	162000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	40	security
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	224372000	USD
CY2021Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	3855000	USD
CY2022Q1	orrf	Number Of Securities Other Than Temporary Impairment NumberOfSecuritiesOtherThanTemporaryImpairment	1	security
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3075000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	3376000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3509000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	79079000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	75367000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	182951000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	177625000	USD
CY2022Q1	orrf	Debt Securities Available For Sale Securities Mortgage Backed Securities And Collateralized Mortgage Obligations Amortized Cost DebtSecuritiesAvailableForSaleSecuritiesMortgageBackedSecuritiesAndCollateralizedMortgageObligationsAmortizedCost	165094000	USD
CY2022Q1	orrf	Debt Securities Available For Sale Securities Mortgage Backed Securities And Collateralized Mortgage Obligations Fair Value DebtSecuritiesAvailableForSaleSecuritiesMortgageBackedSecuritiesAndCollateralizedMortgageObligationsFairValue	157259000	USD
CY2022Q1	orrf	Debt Securities Available For Sale Securities Asset Backed Debt Securities Amortized Cost DebtSecuritiesAvailableForSaleSecuritiesAssetBackedDebtSecuritiesAmortizedCost	117805000	USD
CY2022Q1	orrf	Debt Securities Available For Sale Securities Asset Backed Debt Securities Fair Value DebtSecuritiesAvailableForSaleSecuritiesAssetBackedDebtSecuritiesFairValue	115970000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	548305000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	529730000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	25000	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	1351000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	USD
CY2021Q1	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	1206000	USD
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	25000	USD
CY2021Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	145000	USD
CY2022Q1	orrf	Number Of Investments Securities Partially Sold NumberOfInvestmentsSecuritiesPartiallySold	1	security
CY2021Q1	orrf	Number Of Investments Securities Sold NumberOfInvestmentsSecuritiesSold	14	security
	orrf	Number Of Loans Under Paycheck Protection Program Cares Act NumberOfLoansUnderPaycheckProtectionProgramCARESAct	6500	loan
CY2022Q1	orrf	Small Business Administration Paycheck Protection Program Loan Cares Act Guarantee Percentage SmallBusinessAdministrationPaycheckProtectionProgramLoanCARESActGuaranteePercentage	1
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1978307000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1979986000	USD
CY2022Q1	orrf	Amount Of Loan On Which Review Have Been Made Annually AmountOfLoanOnWhichReviewHaveBeenMadeAnnually	1000000	USD
CY2022Q1	orrf	Amount Of Loan On Which Reviews Require Approval AmountOfLoanOnWhichReviewsRequireApproval	500000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1978307000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1979986000	USD
CY2022Q1	orrf	Number Of Days Of Past Due Assigned As Substandard Rating NumberOfDaysOfPastDueAssignedAsSubstandardRating	P90D
CY2022Q1	orrf	Number Of Notes Split NumberOfNotesSplit	2	note
CY2022Q1	orrf	Appraisals Required Period Interval AppraisalsRequiredPeriodInterval	P18M
CY2022Q1	orrf	Minimum Amount On Which Annual Updated Appraisals For Criticized Loans Is Required MinimumAmountOnWhichAnnualUpdatedAppraisalsForCriticizedLoansIsRequired	250000	USD
CY2022Q1	orrf	Appraisals Required Period Interval AppraisalsRequiredPeriodInterval	P18M
CY2022Q1	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	338000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	338000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	29000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	5747000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	9151000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment	341000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance	341000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	28000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment	6912000	USD
CY2021Q4	us-gaap	Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance	9748000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	6637000	USD
CY2022Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	7000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	10505000	USD
CY2021Q1	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	12000	USD
CY2022Q1	orrf	Financing Receivable Modified Balance End Of Period Number Of Contract FinancingReceivableModifiedBalanceEndOfPeriodNumberOfContract	13	contract
CY2022Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	851000	USD
CY2021Q4	orrf	Financing Receivable Modified Balance End Of Period Number Of Contract FinancingReceivableModifiedBalanceEndOfPeriodNumberOfContract	13	contract
CY2021Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	1089000	USD
CY2022Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	1	contract
CY2021Q1	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0	contract
CY2022Q1	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	238000	USD
CY2022Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	5510000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1978307000	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment90 Days Past Due And Still Accruing FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing	1201000	USD
CY2021Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	6449000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1979986000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21180000	USD
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	300000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	84000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	112000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21508000	USD
CY2020Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	20151000	USD
CY2021Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1000000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	495000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	311000	USD
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	18967000	USD
CY2022Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	6085000	USD
CY2022Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1972222000	USD
CY2022Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	1978307000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	29000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	21479000	USD
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21508000	USD
CY2021Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	7253000	USD
CY2021Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	1972733000	USD
CY2021Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	1979986000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	28000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	21152000	USD
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	21180000	USD
CY2021Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	2661000	USD
CY2020Q4	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	3438000	USD
CY2022Q1	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion	314000	USD
CY2021Q1	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldAccretion	466000	USD
CY2022Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference	243000	USD
CY2021Q1	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference	44000	USD
CY2022Q1	orrf	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Other CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldOther	-73000	USD
CY2021Q1	orrf	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Other CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldOther	56000	USD
CY2022Q1	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	2517000	USD
CY2021Q1	us-gaap	Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYield	3072000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10305000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10515000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	10937000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11119000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y4M24D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P14Y7M6D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	294000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	343000	USD
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	394000	USD
CY2021Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	403000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	868000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1216000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1246000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1269000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1302000	USD
CY2022Q1	orrf	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	9687000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15588000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4651000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	10937000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	18724000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	18724000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	18724000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	18724000	USD
CY2021Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4183000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5458000	USD
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	292000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	334000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3891000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5124000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8415000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4524000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8415000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4232000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	813000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	935000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	766000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	596000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	427000	USD
CY2022Q1	orrf	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	354000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3891000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2022Q1	orrf	Number Of Third Party Broker NumberOfThirdPartyBroker	14	bank
CY2022Q1	orrf	Cash Collateral Held By Counterparty For Derivatives CashCollateralHeldByCounterpartyForDerivatives	0	USD
CY2021Q4	orrf	Cash Collateral Held By Counterparty For Derivatives CashCollateralHeldByCounterpartyForDerivatives	260000	USD
CY2022Q1	orrf	Derivative Instruments Cash Collateral Held From Counterparties DerivativeInstrumentsCashCollateralHeldFromCounterparties	2600000	USD
CY2021Q4	orrf	Derivative Instruments Cash Collateral Held From Counterparties DerivativeInstrumentsCashCollateralHeldFromCounterparties	490000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax	739000	USD
CY2021Q2	orrf	Stock Repurchase Program Additional Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramAdditionalNumberOfSharesAuthorizedToBeRepurchased	562000	shares
CY2022Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	415805	shares
CY2022Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	8900000	USD
CY2022Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	21.35
CY2022Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	562195	shares
CY2022Q1	orrf	Stock Repurchase Program Authorized Percentage Of Outstanding Shares Of Common Stock Remaining StockRepurchaseProgramAuthorizedPercentageOfOutstandingSharesOfCommonStockRemaining	0.05
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	8368000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	10207000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10860000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10975000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	147000	shares
CY2021Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	99000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11007000	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11074000	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.77
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.93
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.76
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.92
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	112223	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2021Q4	orrf	Concentration Risk Credit Risk Financial Instrument Maximum Exposure Liability ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposureLiability	1600000	USD
CY2022Q1	us-gaap	Fair Value Option Aggregate Differences Loans And Long Term Receivables FairValueOptionAggregateDifferencesLoansAndLongTermReceivables	-195000	USD
CY2021Q4	us-gaap	Fair Value Option Aggregate Differences Loans And Long Term Receivables FairValueOptionAggregateDifferencesLoansAndLongTermReceivables	150000	USD
CY2022Q1	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	47000	USD
CY2021Q4	us-gaap	Valuation Allowance For Impairment Of Recognized Servicing Assets Balance ValuationAllowanceForImpairmentOfRecognizedServicingAssetsBalance	79000	USD
CY2022Q1	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	-32000	USD
CY2021Q1	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	-606000	USD
CY2022Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	CONTINGENCIES<div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nature of the Company’s business generates a certain amount of litigation involving matters arising out of the ordinary course of business. Except as described below, in the opinion of management, there are no legal proceedings that might have a material effect on the results of operations, liquidity, or the financial position of the Company at this time.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 25, 2012, SEPTA filed a putative class action complaint in the U.S. District Court for the Middle District of Pennsylvania against the Company, the Bank and certain current and former directors and officers (collectively, the “Orrstown Defendants”). The complaint alleged, among other things, that (i) in connection with the Company’s Registration Statement on Form S-3 dated February 23, 2010 and its Prospectus Supplement dated March 23, 2010, and (ii) during the purported class period of March 24, 2010 through October 27, 2011, the Company issued materially false and misleading statements regarding the Company’s lending practices and financial results, including misleading statements concerning the stringent nature of the Bank’s credit practices and underwriting standards, the quality of its loan portfolio, and the intended use of the proceeds from the Company’s March 2010 public offering of common stock. The complaint asserted claims under Sections 11, 12(a) and 15 of the Securities Act of 1933, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, and sought class certification, unspecified money damages, interest, costs, fees and equitable or injunctive relief. Under the Private Securities Litigation Reform Act of 1995 (“PSLRA”), the Court appointed SEPTA Lead Plaintiff on August 20, 2012.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 4, 2013, SEPTA filed an amended complaint. The amended complaint expanded the list of defendants in the action to include the Company’s former independent registered public accounting firm, Smith Elliott Kearns & Company, LLC (“SEK”), and the underwriters of the Company’s March 2010 public offering of common stock. In addition, among other things, the amended complaint extended the purported 1934 Exchange Act class period from March 15, 2010 through April 5, 2012. </span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 22, 2015, in a 96-page Memorandum, the Court dismissed without prejudice SEPTA’s amended complaint against all defendants, finding that SEPTA failed to state a claim under either the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended. On February 8, 2016, the Court granted SEPTA’s motion for leave to amend again and SEPTA filed its second amended complaint that same day.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 7, 2016, the Court issued an Order and Memorandum granting in part and denying in part defendants’ motions to dismiss SEPTA’s second amended complaint. The Court granted the motions to dismiss the Securities Act claims against all defendants, and granted the motions to dismiss the Exchange Act Section 10(b) and Rule 10b-5 claims against all defendants except Orrstown Financial Services, Inc., Orrstown Bank, Thomas R. Quinn, Jr., Bradley S. Everly, and Jeffrey W. Embly. The Court also denied the motions to dismiss the Exchange Act Section 20(a) claims against Quinn, Everly, and Embly.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 15, 2017, the Orrstown Defendants and SEPTA exchanged expert reports in opposition to and in support of class certification, respectively. On January 15, 2018, the parties exchanged expert rebuttal reports. SEPTA has not yet filed a motion for class certification.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 9, 2018, SEPTA filed a motion to compel the production of Confidential Supervisory Information (CSI) of non-parties the Board of Governors of the FRB and the Pennsylvania Department of Banking and Securities, in the possession of Orrstown and third parties. On August 30, 2018, the FRB filed an unopposed motion to intervene in the Action for the purpose of opposing SEPTA’s motion to compel. On February 12, 2019, the Court denied SEPTA’s motion to compel the production of CSI on the ground that SEPTA had failed to exhaust its administrative remedies.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2019, SEPTA filed a motion for leave to file a third amended complaint. The proposed third amended complaint seeks to reassert the Securities Act claims that the Court dismissed as to all defendants on December 7, 2016, when the Court granted in part and denied in part defendants’ motions to dismiss SEPTA’s second amended complaint. The proposed third amended complaint also seeks to reassert the Exchange Act claims against those defendants that the Court dismissed from the case on December 7, 2016.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 13, 2019, Orrstown filed a motion for protective order to stay discovery pending resolution of SEPTA’s motion for leave to file a third amended complaint. On July 17, 2019, the Court entered an Order partially granting Orrstown’s motion for protective order, ruling that all deposition discovery in the case was stayed pending a decision on SEPTA’s motion for leave to file a third amended complaint. Party and non-party document discovery in the case has largely been completed.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 14, 2020, the Court issued an Order and Memorandum granting SEPTA’s motion for leave to file a third amended complaint. The third amended complaint is now the operative complaint. It reinstates the Orrstown Defendants, as well as SEK and the underwriter defendants, previously dismissed from the case on December 7, 2016. The third amended complaint also revives the previously dismissed Securities Act claim against the Orrstown Defendants, SEK, and the </span></div><div style="margin-bottom:9pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">underwriter defendants. Defendants filed their motions to dismiss the third amended complaint on April 24, 2020. SEPTA’s opposition was filed on July 8, 2020, and Orrstown’s reply brief was filed on August 12, 2020.</span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on February 24, 2020, the Orrstown Defendants, and the underwriter defendants and SEK, separately filed motions under 28 U.S.C. § 1292(b) asking the District Court to certify its February 14, 2020 Order granting leave to file the third amended complaint for interlocutory appeal to the Third Circuit Court of Appeals. The District Court granted those motions on July 17, 2020, and defendants filed their Petition for Permission to Appeal with the Third Circuit on July 27, 2020. The Third Circuit granted permission to appeal the Order pursuant to 28 U.S.C. § 1292(b) on August 13, 2020. Defendants filed their joint Opening Brief in the Third Circuit on November 2, 2020, asking the Court to reverse the district court’s Order. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEPTA filed its responsive brief on December 2, 2020 and defendants filed their reply brief on December 23, 2020. Oral argument was held on February 10, 2021. On September 2, 2021, the Third Circuit affirmed the District Court's February 14, 2020 Order granting SEPTA leave to file a third amended complaint. Defendants' motions to dismiss the third amended complaint are still pending in the District Court. </span></div><div style="margin-bottom:9pt;margin-top:3pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that SEPTA’s allegations and claims against the defendants are without merit, and the Company intends to defend itself vigorously against those claims. It is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation.</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 25, 2022, a customer of the Bank filed a putative class action complaint against the Bank in the Court of Common Pleas of Cumberland County, Pennsylvania in a case captioned </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Alleman, on behalf of himself and all others similarly situated, v. Orrstown Bank</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. The complaint alleges, among other things, that the Bank breached its account agreements by charging certain overdraft fees. The complaint seeks a refund of all allegedly improper fees, damages in an amount to be proven at trial, attorneys’ fees and costs, and an injunction against the Bank’s allegedly improper overdraft practices. This lawsuit is similar to lawsuits recently filed against other financial institutions pertaining to overdraft fee disclosures. Based on information available at present, it is not possible at this time to reasonably estimate possible losses, or even a range of reasonably possible losses, in connection with the litigation. Accordingly, the Company has not recognized any liability associated with this action. The Bank believes that the allegations and claims against the Bank are without merit, and intends to defend itself vigorously against those claims.</span></div>

Files In Submission

Name	View Source	Status
0000826154-22-000128-index-headers.html	Edgar Link	pending
0000826154-22-000128-index.html	Edgar Link	pending
0000826154-22-000128.txt	Edgar Link	pending
0000826154-22-000128-xbrl.zip	Edgar Link	pending
ex3112022-10qxq1.htm	Edgar Link	pending
ex3122022-10qxq1.htm	Edgar Link	pending
ex3212022-10qxq1.htm	Edgar Link	pending
ex3222022-10qxq1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
orrf-20220331.htm	Edgar Link	pending
orrf-20220331.xsd	Edgar Link	pending
orrf-20220331_cal.xml	Edgar Link	unprocessable
orrf-20220331_def.xml	Edgar Link	unprocessable
orrf-20220331_htm.xml	Edgar Link	completed
orrf-20220331_lab.xml	Edgar Link	unprocessable
orrf-20220331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORRF
ORRSTOWN FINANCIAL SERVICES INC Stock $orrf

2022 Q1 Form 10-Q Financial Statement

#000082615422000128 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORRF ORRSTOWN FINANCIAL SERVICES INC Stock $orrf

2022 Q1 Form 10-Q Financial Statement

#000082615422000128 Filed on May 05, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORRF
ORRSTOWN FINANCIAL SERVICES INC Stock $orrf